Impact of age and timing of hip orthosis on treatment outcomes in infants with developmental dysplasia of the hip: A systematic review and meta-analysis
- PMID: 40109511
- PMCID: PMC11919298
- DOI: 10.1016/j.jcot.2025.102944
Impact of age and timing of hip orthosis on treatment outcomes in infants with developmental dysplasia of the hip: A systematic review and meta-analysis
Abstract
Background: Developmental Dysplasia of the Hip (DDH) is a prevalent pediatric condition affecting 1-3% of newborns worldwide. Early treatment is crucial to prevent long-term complications such as residual dysplasia, avascular necrosis (AVN), and osteoarthritis. Despite the widespread use of the Pavlik harness, the optimal timing of hip orthosis initiation remains a topic of debate. This systematic review and meta-analysis evaluate the impact of age and timing of hip orthosis application on treatment outcomes in infants with DDH.
Methods: This systematic review was registered on PROSPERO (Registration No. CRD42025638433). A comprehensive literature search was conducted in PubMed, Scopus, and Cochrane Library for studies published between 2000 and 2024. Twenty-two studies meeting inclusion criteria were analyzed, focusing on success rates, healing times, and complications such as AVN and residual dysplasia. Data were pooled for meta-analysis, and statistical analyses were performed using a random-effects model to assess the impact of treatment timing.
Results: Infants treated before 3 months of age achieved a pooled success rate of 88.79 % (SE: 0.57 %), with lower complication rates, including AVN (0.89 %, SE: 0.18 %) and residual dysplasia (1.80 %, SE: 0.25 %). In contrast, treatment initiation between 3 and 6 months had a slightly lower success rate of 87.78 % (SE: 0.34 %), but with higher AVN (9.66 %, SE: 0.30 %) and residual dysplasia (20.27 %, SE: 0.40 %) rates. The Pavlik harness and Tübingen hip flexion splint were most effective in early-treated cases, whereas later treatment initiation or severe presentations resulted in less favorable outcomes.
Conclusion: Early treatment initiation, particularly before 3 months of age, significantly improves treatment success and reduces long-term complications. These findings emphasize the necessity of early screening and timely intervention to optimize outcomes. Future research should focus on refining treatment protocols for delayed presentations and improving management strategies for severe dysplasia.
Level of evidence: Level IV.
Keywords: DDH; Developmental dysplasia of the hip; Hip orthosis; Pavlik harness; Treatment timing.
© 2025 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Splinting for the non-operative management of developmental dysplasia of the hip (DDH) in children under six months of age.Cochrane Database Syst Rev. 2022 Oct 10;10(10):CD012717. doi: 10.1002/14651858.CD012717.pub2. Cochrane Database Syst Rev. 2022. PMID: 36214650 Free PMC article.
-
The efficacy of Tübingen splint in developmental dysplasia of the hip in children under 6 months: A systematic review and meta-analysis.Medicine (Baltimore). 2025 Aug 8;104(32):e43753. doi: 10.1097/MD.0000000000043753. Medicine (Baltimore). 2025. PMID: 40797429 Free PMC article.
-
Is Prior Nonoperative or Operative Treatment of Dysplasia of the Hip Associated With Poorer Results of Periacetabular Osteotomy?Clin Orthop Relat Res. 2024 Nov 1;482(11):1987-1996. doi: 10.1097/CORR.0000000000003150. Epub 2024 Jun 25. Clin Orthop Relat Res. 2024. PMID: 38917051
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
-
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004863. doi: 10.1002/14651858.CD004863.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004863. doi: 10.1002/14651858.CD004863.pub3. PMID: 16856062 Updated.
References
-
- Weinstein S.L., Holt J.B. The Pediatric and Adolescent Hip. Springer International Publishing; 2019. Developmental dysplasia of the hip in young children; pp. 75–129. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Research Materials